Disclosures for "Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)"
-
Dr. Swart has received research support from National Health and Medical Research Council. Dr. Swart has received personal compensation in the range of $5,000-$9,999 for serving as a MS Masters Forum Attendee (sponsored education) with Merck.
-
Dr. Garg has nothing to disclose.
-
Dr. Yiannikas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
-
Prof. Vucic has a non-compensated relationship as a Member-Advisory Board with Biogen Idec Australia that is relevant to AAN interests or activities. Prof. Vucic has a non-compensated relationship as a Honorarium with Merkc Serono Ausralia that is relevant to AAN interests or activities.
-
Dr. Pollard has nothing to disclose.
-
Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam and Sanofi. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL.
-
Dr. Silsby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silsby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
-
The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
-
Dr. Spies has nothing to disclose.
-
Dr. Park has a non-compensated relationship as a Board Member with Toxic Neuropathy Consortium, Peripheral Nerve Society that is relevant to AAN interests or activities.